Industrial Scale Manufacturing and Downstream Processing of PLGA-Based Nanomedicines Suitable for Fully Continuous Operation

Despite the efficacy and potential therapeutic benefits that poly(lactic-co-glycolic acid) (PLGA) nanomedicine formulations can offer, challenges related to large-scale processing hamper their clinical and commercial development. Major hurdles for the launch of a polymeric nanocarrier product on the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Maria Camilla Operti, Alexander Bernhardt, Vladimir Sincari, Eliezer Jager, Silko Grimm, Andrea Engel, Martin Hruby, Carl Gustav Figdor, Oya Tagit
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-01-01
coleção:	Pharmaceutics
Assuntos:	PLGA poly(lactic-co-glycolic acid) nanomedicine nanoparticles scale-up manufacturing clinical translation
Acesso em linha:	https://www.mdpi.com/1999-4923/14/2/276
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!